SDF-1 in myocardial repair

Gene Therapy

Volumn 19, Issue 6, 2012, Pages 583-587

  Penn, M S ^a,b,c   Pastore, J ^c   Miller, T ^c   Aras, R ^c  

^a SUMMA HEALTH SYSTEM   (United States)

^b Northeast Ohio Medical University   (United States)

^c Juventas Therapeutics Inc   (United States)

Author keywords

acute myocordial infarction; chemokines; regenerative medicine; stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; JVS 100; PLACEBO; PLASMID DNA; STROMAL CELL DERIVED FACTOR 1; TROPONIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; CELL HOMING; CELL SURVIVAL; ECHOCARDIOGRAPHY; GENE DOSAGE; GENE OVEREXPRESSION; GENETIC ENGINEERING; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL GENE THERAPY;

CHEMOKINE CXCL12; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; VENTRICULAR REMODELING;

ANIMALIA;

EID: 84862004351     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2012.32     Document Type: Review

References (34)

1. Askari A, Unzek S, Popovic ZB, Goldman CK, Forudi F, kiedrowski M et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 2003; 362: 697-703. (Pubitemid 37101067)
2. Nelson TJ, Faustino RS, Chiriac A, Crespo-Diaz R, Behfar A, Terzic A. CXCR4 +FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 2008; 26: 1464-1473.
3. Deglurkar I, Mal N, Mills WR, Popovic ZB, McCarthy PM, Blackstone EH et al. Mechanical and electrical effects of cell based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther 2006; 17: 1144-1151. (Pubitemid 44749715)
4. Sundararaman S, Miller TJ, Pastore J, Kiedrowski MJ, Aras R, Penn MS. Plasmid based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Therapy 2011; 18: 867-873.
5. Zhang M, Mal N, kiedrowski M, Chacko M, Askari AT, Popovic ZB et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21: 3197-3207. (Pubitemid 47565538)
6. Unzek S, Zhang M, Mal N, Mills WR, laurita KR, Penn MS. SDF-1 recruits cardiac stem cell like cells that depolarize in vivo. Cell Transplant 2007; 16: 879-886. (Pubitemid 351448605)
7. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010; 107: 913-922.
8. Dong F, Finan A, Weber K, Penn MS. Role of mesenchymal stem cell SDF-1 release and myocardial CXCR4 expression in post-MI cardiac repair. Circulation 2011; 124: A18178.
9. Rodrigues CO, Shehadeh LA, Hoosien M, Otero V, Chopra I, Tsinoremas NF et al. Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells. PLoS ONE 2011; 6: e24013.
10. Penn MS, Zhang M, Deglurkar I, Topol EJ. Role of stem cell homing in myocardial regeneration. Int J Cardiol 2004; 95 (Suppl 1): S23-S25. (Pubitemid 39178504)
11. Penn MS, Francis GS, Ellis SG, Young JB, McCarthy PM, Topol EJ. Autologous cell therapy for the treatment of damaged myocardium. Prog Cardiovasc Dis 2002; 45: 21-32. (Pubitemid 34809390)
12. Penn MS, Pastore J, Aras R, Rouy D, Clemens R, Schaer GL et al. Initial results from a first-in-man study delivering non-viral gene therapy hSDF-1 (JVS-100) to treat ischemic heart failure. Mol Ther 2011; 19: S40.
13. Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT et al. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J 2010; 37: 412-420.
14. Assmus B, Iwasaki M, Schachinger V, Roexe T, Koyanagi M, Iekushi K et al. Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart Journal 2011; e-pub ahead of print 15 December 2011; doi:10.1093/eurheartj/ehr388.
15. Schachinger V, Aicher A, Dobert N, Rover R, Diener J, Fichtlscherer S et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 2008; 118: 1425-1432.
16. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221. (Pubitemid 44427445)
17. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705. (Pubitemid 32290358)
18. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349. (Pubitemid 32803022)
19. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 2010; 56: 721-734.
20. Penn MS. Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ Res 2009; 104: 1133-1135.
21. Penn MS, Anwaruddin S, Nair R, Ellis S. From mice to men. Commonalities in physiology for stem cell-based cardiac repair. J Am Coll Cardiol 2009; 54: 2287-2289.
22. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 2010; 19: 399-408.
23. Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784. (Pubitemid 40577712)
24. Mayorga ME, Dong F, Sundararaman S, Huang Y, Jiang Y, Howe PH et al. Central role for disabled-2 in mesenchymal stem cell cardiac protein expression and functional consequences after engraftment in acute myocardial infarction. Stem Cells Dev 2011; 20: 681-693.
25. Mayorga ME, Penn MS. miR-145 is differentially regulated by TGFb1 and ischemia and targets disabled-2 expression and wnt/b-catenin activity. J Cell Mol Med 2011; e-pub ahead of print 18 July 2011; doi:10.1111/j.1582-4934.2011. 01385.x.
26. Schenk S, Mal N, Finan A, Zhang M, kiedrowski M, Popovic Z et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007; 25: 245-251. (Pubitemid 46052996)
27. Mills WR, Mal N, kiedrowski M, Unger R, Forudi F, Popovic ZB et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 2007; 42: 304-314. (Pubitemid 46135598)
28. Costa AR, Panda NC, Yong S, Mayorga ME, Pawlowski GP, Fan K et al. Optical mapping of cryoinjured rat myocardium grafted with mesenchymal stem cells. Am j physiol Heart circ physiol 2012; 302: H270-H277.
29. Radke PW, Heinl-Green A, Frass OM, Griesenbach U, Ferrari S, Geddes DM et al. Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch. Gene therapy 2004; 11: 1249-1255. (Pubitemid 39173431)
30. Carlsson M, Osman NF, Ursell PC, Martin AJ, Saeed M. Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium. Am j physiol Heart circ physiol 2008; 295: H522-H532.
31. Penn MS, Topol E. The challenge for stem cell therapy. In: Penn MS (ed). Stem Cells and Myocardial Regeneration. Humana Press: Totowa, 2007, pp 1-8.
32. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011; 124: 304-313.
33. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T et al. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011; 109: 428-436.
34. Penn MS, Dong F, Klein S, Mayorga ME. Stem cells for myocardial regeneration. Clin pharmacol ther 2011; 90: 499-501.